市場調査レポート
商品コード
1422545

女性用プロバイオティクス・サプリメントの世界市場 2024-2028

Global Feminine Probiotic Supplement Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 167 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
女性用プロバイオティクス・サプリメントの世界市場 2024-2028
出版日: 2024年01月31日
発行: TechNavio
ページ情報: 英文 167 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

女性用プロバイオティクス・サプリメント市場は2023-2028年に6億6,082万米ドル、予測期間中のCAGRは7.7%で成長すると予測されます。

当レポートでは、女性用プロバイオティクス・サプリメント市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、消化器系問題の有病率の増加、プロバイオティクス原料の持続可能性と倫理的調達の増加、ストレス事例の増加によって牽引されています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 7.22%
CAGR 7.7%
増分額 6億6,082万米ドル

本調査では、今後数年間の女性用プロバイオティクス・サプリメント市場の成長を促進する主な理由の一つとして、女性用プロバイオティクス・サプリメントの研究開発重視の高まりを挙げています。また、体重管理製品の需要増加、プレバイオティクスやシンバイオティクスの採用増加も市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 女性用プロバイオティクス・サプリメントの世界市場 2018-2022
  • 流通チャネルセグメント分析 2018-2022
  • タイプセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:流通チャネル別

  • 市場セグメント
  • 比較:流通チャネル別
  • オフライン:市場規模と予測 2023-2028
  • オンライン:市場規模と予測 2023-2028
  • 市場機会:流通チャネル別

第7章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • タブレット:市場規模と予測 2023-2028
  • カプセル:市場規模と予測 2023-2028
  • 経口液製剤:市場規模と予測 2023-2028
  • その他:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • 日本:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Amway Corp.
  • Anlit Ltd.
  • Bayer AG
  • BioGaia AB
  • Chr Hansen Holding AS
  • Church and Dwight Co. Inc.
  • DuPont de Nemours Inc.
  • Kirin Holdings Co. Ltd.
  • Koninklijke DSM NV
  • Lifeway Foods Inc.
  • OrganiCare
  • PanTheryx Inc.
  • Probi AB
  • Reckitt Benckiser Group Plc
  • The Clorox Co.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global feminine probiotic supplement market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Offline - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by Distribution Channel ($ million)
  • Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits44: Chart on Type - Market share 2023-2028 (%)
  • Exhibits45: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by Type
  • Exhibits47: Data Table on Comparison by Type
  • Exhibits48: Chart on Tablets - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Tablets - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Tablets - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Tablets - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Capsules - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Capsules - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Capsules - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Capsules - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Oral liquid - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Oral liquid - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Oral liquid - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Oral liquid - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Market opportunity by Type ($ million)
  • Exhibits65: Data Table on Market opportunity by Type ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2023 and 2028
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: Amway Corp. - Overview
  • Exhibits116: Amway Corp. - Product / Service
  • Exhibits117: Amway Corp. - Key offerings
  • Exhibits118: Anlit Ltd. - Overview
  • Exhibits119: Anlit Ltd. - Product / Service
  • Exhibits120: Anlit Ltd. - Key offerings
  • Exhibits121: Bayer AG - Overview
  • Exhibits122: Bayer AG - Business segments
  • Exhibits123: Bayer AG - Key news
  • Exhibits124: Bayer AG - Key offerings
  • Exhibits125: Bayer AG - Segment focus
  • Exhibits126: BioGaia AB - Overview
  • Exhibits127: BioGaia AB - Business segments
  • Exhibits128: BioGaia AB - Key news
  • Exhibits129: BioGaia AB - Key offerings
  • Exhibits130: BioGaia AB - Segment focus
  • Exhibits131: Chr Hansen Holding AS - Overview
  • Exhibits132: Chr Hansen Holding AS - Business segments
  • Exhibits133: Chr Hansen Holding AS - Key news
  • Exhibits134: Chr Hansen Holding AS - Key offerings
  • Exhibits135: Chr Hansen Holding AS - Segment focus
  • Exhibits136: Church and Dwight Co. Inc. - Overview
  • Exhibits137: Church and Dwight Co. Inc. - Business segments
  • Exhibits138: Church and Dwight Co. Inc. - Key offerings
  • Exhibits139: Church and Dwight Co. Inc. - Segment focus
  • Exhibits140: DuPont de Nemours Inc. - Overview
  • Exhibits141: DuPont de Nemours Inc. - Business segments
  • Exhibits142: DuPont de Nemours Inc. - Key news
  • Exhibits143: DuPont de Nemours Inc. - Key offerings
  • Exhibits144: DuPont de Nemours Inc. - Segment focus
  • Exhibits145: Kirin Holdings Co. Ltd. - Overview
  • Exhibits146: Kirin Holdings Co. Ltd. - Business segments
  • Exhibits147: Kirin Holdings Co. Ltd. - Key offerings
  • Exhibits148: Kirin Holdings Co. Ltd. - Segment focus
  • Exhibits149: Koninklijke DSM NV - Overview
  • Exhibits150: Koninklijke DSM NV - Business segments
  • Exhibits151: Koninklijke DSM NV - Key news
  • Exhibits152: Koninklijke DSM NV - Key offerings
  • Exhibits153: Koninklijke DSM NV - Segment focus
  • Exhibits154: Lifeway Foods Inc. - Overview
  • Exhibits155: Lifeway Foods Inc. - Product / Service
  • Exhibits156: Lifeway Foods Inc. - Key offerings
  • Exhibits157: OrganiCare - Overview
  • Exhibits158: OrganiCare - Product / Service
  • Exhibits159: OrganiCare - Key offerings
  • Exhibits160: PanTheryx Inc. - Overview
  • Exhibits161: PanTheryx Inc. - Product / Service
  • Exhibits162: PanTheryx Inc. - Key offerings
  • Exhibits163: Probi AB - Overview
  • Exhibits164: Probi AB - Business segments
  • Exhibits165: Probi AB - Key offerings
  • Exhibits166: Probi AB - Segment focus
  • Exhibits167: Reckitt Benckiser Group Plc - Overview
  • Exhibits168: Reckitt Benckiser Group Plc - Business segments
  • Exhibits169: Reckitt Benckiser Group Plc - Key offerings
  • Exhibits170: Reckitt Benckiser Group Plc - Segment focus
  • Exhibits171: The Clorox Co. - Overview
  • Exhibits172: The Clorox Co. - Business segments
  • Exhibits173: The Clorox Co. - Key offerings
  • Exhibits174: The Clorox Co. - Segment focus
  • Exhibits175: Inclusions checklist
  • Exhibits176: Exclusions checklist
  • Exhibits177: Currency conversion rates for US$
  • Exhibits178: Research methodology
  • Exhibits179: Validation techniques employed for market sizing
  • Exhibits180: Information sources
  • Exhibits181: List of abbreviations
目次
Product Code: IRTNTR73087

Abstract

The feminine probiotic supplement market is forecasted to grow by USD 660.82 mn during 2023-2028, accelerating at a CAGR of 7.7% during the forecast period. The report on the feminine probiotic supplement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of digestive problems, growing sustainability and ethical sourcing of probiotic ingredients, and increasing cases of stress.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.22%
CAGR7.7%
Incremental Value$660.82mn

Technavio's feminine probiotic supplement market is segmented as below:

By Distribution Channel

  • Offline
  • Online

By Type

  • Tablets
  • Capsules
  • Oral liquid
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing emphasis on r and d of feminine probiotic supplements as one of the prime reasons driving the feminine probiotic supplement market growth during the next few years. Also, rise in demand for weight management products and rising adoption of prebiotics and synbiotics will lead to sizable demand in the market.

The report on the feminine probiotic supplement market covers the following areas:

  • Feminine probiotic supplement market sizing
  • Feminine probiotic supplement market forecast
  • Feminine probiotic supplement market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading feminine probiotic supplement market vendors that include Amway Corp., Bayer AG, BioGaia AB, Chr Hansen Holding AS, Church and Dwight Co. Inc., DuPont de Nemours Inc., Kirin Holdings Co. Ltd., Koninklijke DSM NV, PanTheryx Inc., Probi AB, Reckitt Benckiser Group Plc, The Clorox Co., Anlit Ltd., Lifeway Foods Inc., and OrganiCare. Also, the feminine probiotic supplement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global feminine probiotic supplement market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global feminine probiotic supplement market 2018 - 2022 ($ million)
  • 4.2 Distribution channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ million)
  • 4.3 Type Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Offline - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Offline - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
  • 6.4 Online - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Distribution Channel
  • Exhibit 42: Market opportunity by Distribution Channel ($ million)
  • Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 44: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
  • Exhibit 46: Chart on Comparison by Type
  • Exhibit 47: Data Table on Comparison by Type
  • 7.3 Tablets - Market size and forecast 2023-2028
  • Exhibit 48: Chart on Tablets - Market size and forecast 2023-2028 ($ million)
  • Exhibit 49: Data Table on Tablets - Market size and forecast 2023-2028 ($ million)
  • Exhibit 50: Chart on Tablets - Year-over-year growth 2023-2028 (%)
  • Exhibit 51: Data Table on Tablets - Year-over-year growth 2023-2028 (%)
  • 7.4 Capsules - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Capsules - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on Capsules - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on Capsules - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Capsules - Year-over-year growth 2023-2028 (%)
  • 7.5 Oral liquid - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Oral liquid - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Data Table on Oral liquid - Market size and forecast 2023-2028 ($ million)
  • Exhibit 58: Chart on Oral liquid - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Oral liquid - Year-over-year growth 2023-2028 (%)
  • 7.6 Others - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.7 Market opportunity by Type
  • Exhibit 64: Market opportunity by Type ($ million)
  • Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Japan - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.9 China - Market size and forecast 2023-2028
  • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
  • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
  • Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 Amway Corp.
  • Exhibit 115: Amway Corp. - Overview
  • Exhibit 116: Amway Corp. - Product / Service
  • Exhibit 117: Amway Corp. - Key offerings
  • 12.4 Anlit Ltd.
  • Exhibit 118: Anlit Ltd. - Overview
  • Exhibit 119: Anlit Ltd. - Product / Service
  • Exhibit 120: Anlit Ltd. - Key offerings
  • 12.5 Bayer AG
  • Exhibit 121: Bayer AG - Overview
  • Exhibit 122: Bayer AG - Business segments
  • Exhibit 123: Bayer AG - Key news
  • Exhibit 124: Bayer AG - Key offerings
  • Exhibit 125: Bayer AG - Segment focus
  • 12.6 BioGaia AB
  • Exhibit 126: BioGaia AB - Overview
  • Exhibit 127: BioGaia AB - Business segments
  • Exhibit 128: BioGaia AB - Key news
  • Exhibit 129: BioGaia AB - Key offerings
  • Exhibit 130: BioGaia AB - Segment focus
  • 12.7 Chr Hansen Holding AS
  • Exhibit 131: Chr Hansen Holding AS - Overview
  • Exhibit 132: Chr Hansen Holding AS - Business segments
  • Exhibit 133: Chr Hansen Holding AS - Key news
  • Exhibit 134: Chr Hansen Holding AS - Key offerings
  • Exhibit 135: Chr Hansen Holding AS - Segment focus
  • 12.8 Church and Dwight Co. Inc.
  • Exhibit 136: Church and Dwight Co. Inc. - Overview
  • Exhibit 137: Church and Dwight Co. Inc. - Business segments
  • Exhibit 138: Church and Dwight Co. Inc. - Key offerings
  • Exhibit 139: Church and Dwight Co. Inc. - Segment focus
  • 12.9 DuPont de Nemours Inc.
  • Exhibit 140: DuPont de Nemours Inc. - Overview
  • Exhibit 141: DuPont de Nemours Inc. - Business segments
  • Exhibit 142: DuPont de Nemours Inc. - Key news
  • Exhibit 143: DuPont de Nemours Inc. - Key offerings
  • Exhibit 144: DuPont de Nemours Inc. - Segment focus
  • 12.10 Kirin Holdings Co. Ltd.
  • Exhibit 145: Kirin Holdings Co. Ltd. - Overview
  • Exhibit 146: Kirin Holdings Co. Ltd. - Business segments
  • Exhibit 147: Kirin Holdings Co. Ltd. - Key offerings
  • Exhibit 148: Kirin Holdings Co. Ltd. - Segment focus
  • 12.11 Koninklijke DSM NV
  • Exhibit 149: Koninklijke DSM NV - Overview
  • Exhibit 150: Koninklijke DSM NV - Business segments
  • Exhibit 151: Koninklijke DSM NV - Key news
  • Exhibit 152: Koninklijke DSM NV - Key offerings
  • Exhibit 153: Koninklijke DSM NV - Segment focus
  • 12.12 Lifeway Foods Inc.
  • Exhibit 154: Lifeway Foods Inc. - Overview
  • Exhibit 155: Lifeway Foods Inc. - Product / Service
  • Exhibit 156: Lifeway Foods Inc. - Key offerings
  • 12.13 OrganiCare
  • Exhibit 157: OrganiCare - Overview
  • Exhibit 158: OrganiCare - Product / Service
  • Exhibit 159: OrganiCare - Key offerings
  • 12.14 PanTheryx Inc.
  • Exhibit 160: PanTheryx Inc. - Overview
  • Exhibit 161: PanTheryx Inc. - Product / Service
  • Exhibit 162: PanTheryx Inc. - Key offerings
  • 12.15 Probi AB
  • Exhibit 163: Probi AB - Overview
  • Exhibit 164: Probi AB - Business segments
  • Exhibit 165: Probi AB - Key offerings
  • Exhibit 166: Probi AB - Segment focus
  • 12.16 Reckitt Benckiser Group Plc
  • Exhibit 167: Reckitt Benckiser Group Plc - Overview
  • Exhibit 168: Reckitt Benckiser Group Plc - Business segments
  • Exhibit 169: Reckitt Benckiser Group Plc - Key offerings
  • Exhibit 170: Reckitt Benckiser Group Plc - Segment focus
  • 12.17 The Clorox Co.
  • Exhibit 171: The Clorox Co. - Overview
  • Exhibit 172: The Clorox Co. - Business segments
  • Exhibit 173: The Clorox Co. - Key offerings
  • Exhibit 174: The Clorox Co. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 175: Inclusions checklist
  • Exhibit 176: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 177: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 178: Research methodology
  • Exhibit 179: Validation techniques employed for market sizing
  • Exhibit 180: Information sources
  • 13.5 List of abbreviations
  • Exhibit 181: List of abbreviations